Quanovate Tech, Inc. has voluntarily discontinued a series of advertising claims for its Mira Fertility Monitor and Test Wands following a challenge by The Procter & Gamble Company.
The challenge was brought through BBB National Programs’ National Advertising Division, a body that provides independent self-regulation and dispute resolution services across the United States.
P&G and Quanovate compete directly in the fertility monitor and test wand market, making the advertising dispute particularly significant for both companies.
P&G’s challenge targeted comparative, performance, and superiority claims that Quanovate had been making in its advertising for the Mira Fertility Monitor and Test Wands.
Rather than contest the challenge, Quanovate agreed during the inquiry to permanently discontinue all of the claims P&G had raised concerns about.
The National Advertising Division did not review the claims on their merits, as Quanovate’s voluntary withdrawal resolved the matter before any formal assessment was needed.
Under the terms of the self-regulatory process, the voluntarily discontinued claims will be treated as though NAD had formally recommended their removal and Quanovate had agreed to comply.
This means Quanovate is held to the same compliance standards as companies that receive a direct NAD ruling against their advertising.
In its advertiser statement, Quanovate stated it “respects the self-regulatory process and thanks NAD for its time.”
The National Advertising Division reviews national advertising across all media, with its decisions designed to set consistent standards for truthfulness and accuracy in advertising throughout the country.
Those standards are intended to deliver meaningful protection to consumers while also creating fair competitive conditions for businesses operating in the same markets.
The fertility tracking device market has grown considerably in recent years, with multiple companies competing on claims of accuracy, reliability, and scientific backing for their products.
Advertising disputes in the sector reflect the commercial stakes involved, as performance claims can be a significant driver of consumer purchasing decisions in this category.
P&G, one of the world’s largest consumer goods companies, has a broad portfolio of health and personal care products and has previously used the NAD process to challenge competitor advertising in contested markets.